Anne Wojcicki on Genetic Testing, Your Data and The Next Innovation
Interactive Video
•
Business
•
University
•
Hard
Wayground Content
FREE Resource
The transcript discusses 23andMe's transition to a public company, focusing on new opportunities in therapeutics and online healthcare. It addresses challenges in drug development, particularly in collaboration with GSK, and the decline in home DNA kit sales due to privacy concerns. The company emphasizes physician education in genetics and the importance of genetic diversity in databases. It also explores the implications of insurance on data privacy and the challenges of precision medicine due to healthcare incentives.
Read more
1 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What new insight or understanding did you gain from this video?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
